InvestorsHub Logo

farrell90

09/30/21 11:19 AM

#376696 RE: KMBJN #376692

Hopefully we will get better data regarding delta covid infections.

IPIX might be better off employing lobbyists than funding more studies. It is hard to compete with Big pharma and their connections.

It is puzzling such a promising antiviral as Brilacidin has to squeak so slowly through the clinical studies.

Where is the money all the politicians have promised?

GLTA,

Farrell